Page last updated: 2024-12-06
acryloxide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
acryloxide: copolymer developed as dental cement & tested as bone cement [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 74919 |
| SCHEMBL ID | 278164 |
| SCHEMBL ID | 12103060 |
| SCHEMBL ID | 1433395 |
| MeSH ID | M0143106 |
Synonyms (35)
| Synonym |
|---|
| nsc32616 |
| 2051-76-5 |
| acrylic anhydride |
| nsc-32616 |
| 2-propenoic acid, anhydride |
| 61932-59-0 |
| prop-2-enoyl prop-2-enoate |
| AKOS006345449 |
| FT-0658651 |
| A814633 |
| acryloxide |
| nsc 32616 |
| unii-m4bys5vwg3 |
| einecs 218-128-2 |
| m4bys5vwg3 , |
| SCHEMBL278164 |
| acrylic acid anhydride |
| SCHEMBL12103060 |
| SCHEMBL1433395 |
| mfcd00048146 |
| 2-propenoic acid anhydride |
| 2-propenoic acid, 1,1'-anhydride |
| BBL104050 |
| prop-2-enoic anhydride |
| STL557864 |
| acrylic anhydride (0.1% bht added as inhibitor) |
| acrylic anhydride min. 90% |
| SY129262 |
| acrylic anhydride (stabl. with 10% 4-methoxyphenol) |
| AS-49546 |
| DTXSID70942685 |
| AMY40703 |
| CS-0119936 |
| I11488 |
| EN300-206271 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (4)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.66
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||